More than 250,000 women and almost 2,000 men will be diagnosed with invasive and in situ breast cancer this year, and it will take more than 40,000 lives in the United States and 500,000 worldwide. Despite years of campaigns to raise awareness, ever expanding screening programs, increased fundraising efforts and research, breast cancer incidence and mortality have not changed significantly.

So we ask you, why not now?

We now have the tools, information, resources and wisdom to create a global strategy to end breast cancer, and setting a deadline is the essential first step. Our understanding of the biology, etiology and genetics of breast cancer has increased dramatically. New disciplines have shed light on the process of innovation and how organizational systems evolve. And of course our capacity to gather, synthesize and analyze information is beyond anything even conceivable 20 years ago.

By leveraging all available resources in a collaborative and rapid research process, it will be possible to catalyze the development of innovative ideas that will ultimately end breast cancer.

Read Our Reports

·         Breast Cancer Deadline 2020^® Progress Report 2011—Ending Breast Cancer: A Baseline Status Report

·         Breast Cancer Deadline 2020^® Letter to the Scientists

·         Breast Cancer Deadline 2020^® White Paper

·         Breast Cancer Deadline 2020^® Executive Summary

·         Breast Cancer Deadline 2020^® Call to Action, NBCC’s Winter 2011 Newsletter